Case studies in bioinformatics and target discovery, by example

Case Study 1
Novel targets generated from gene expression breast cancer data.

Case Study 2
The link between diabetes and brain cancer.

Speaker
Dr Darrol Baker, InforMax

12.00 - 13.30
Tivoli

Enabling Discoveries Using the Genome for functional Research

Enabling the Next Phase of Genomic Discovery: An update on the Applera Corporation Genomic assays initiative
Steve Picton, Ph.D., SNP Account Manager Europe, Business Development, Applied Biosystems

The ABI PRISM® 7000 Sequence Detection System : Overview of possible real-time PCR applications
Roland Wicki, Ph.D., Business Development Specialist, Applied Biosystems

Advancing your research with the New ABI PRISM 3100-Avant Genetic Analyzer
Kathryn Gunning, Product Development Scientist, DNA Platforms Group, Applied Biosystems

12.30 - 14.00
Oberlin

New insights in the treatment of lysosomal storage diseases.

Preliminary Programme

Gaucher Registry: 10 Years Experience with Enzyme Replacement Therapy in Gaucher Disease
Dr. J. Charrow, Children's Memorial Hospital, Chicago, USA

Enzyme Replacement Therapy for MPSI: Results of the Phase III Trial
Dr. J. Muenzer, University of Northern Carolina, Chapel Hill, USA

New Findings in Enzyme Replacement Therapy for Fabry Disease
Prof. Dr. H. Aerts, AMC, Amsterdam, The Netherlands

Open Questions around the Therapies for Lysosomal Storage Diseases. Closure.
Dr. D. Meeker, Genzyme Therapeutics, France

12.30 - 14.00
Hotel Hilton
Room Orangerie
Ground floor

MagNA Pure Lightcycler and Lightcycler-The "PCR Workflow Solution for Mutation Analysis".

Versatile Use of LightCycler and MagNA Pure LC in a Clinical Setting for Routine and Research
C. Aslanidis, Regensburg, Germany

Automated assay for foetal DNA analysis in maternal serum
J.M. Costa, Paris, France

LightCycler applications in Cystic Fibrosis and Duchenne muscular dystrophy: quantitative real time PCR for transcript analysis and carrier detection
S. Gallati, Bern, Switzerland

Back